RHENMAN & PARTNERS ASSET MANAGEMENT AB – Esperion Therapeutics, Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$7.31M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
+5.35%
quarter
Esperion Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.59M | $6.7 | 900K | |
| Q2 2022 | share | Decrease | -8.31% | -81.58K shares | 1.16M | $6.36 | 900K |
| Q1 2022 | share | Decrease | -1.84% | -18.41K shares | -405K | $4.64 | 981.58K |
| Q4 2021 | share | Increase | +60.70% | 377.73K shares | -2.53M | $4.96 | 1M |
| Q3 2021 | share | Increase | +8.74% | 50K shares | -4.60M | $12.05 | 622.26K |
| Q2 2021 | share | Decrease | -3.37% | -19.95K shares | -4.50M | $21.15 | 572.26K |
| Q1 2021 | share | 0.00% | 0 shares | 1.21M | $28.05 | 592.22K | |
| Q4 2020 | share | Increase | +30.16% | 137.22K shares | -1.51M | $26 | 592.22K |
| Q3 2020 | share | Increase | +7.06% | 30K shares | -4.89M | $37.17 | 455K |
| Q2 2020 | share | Decrease | -28.31% | -167.79K shares | 3.11M | $51.31 | 425K |
| Q1 2020 | share | Decrease | -10.18% | -67.20K shares | -20.66M | $31.53 | 592.79K |
| Q4 2019 | share | Increase | +0.63% | 4.14K shares | 15.31M | $59.63 | 660K |
| Q3 2019 | share | Increase | +59.15% | 243.76K shares | 4.87M | $36.66 | 655.85K |
| Q2 2019 | share | Decrease | -14.11% | -67.67K shares | -92K | $46.52 | 412.09K |
| Q1 2019 | share | Increase | +35.54% | 125.80K shares | 2.98M | $40.15 | 479.76K |
| Q4 2018 | share | 0.00% | 0 shares | 577K | $46 | 353.96K | |
| Q3 2018 | share | Decrease | -12.89% | -52.4K shares | -220K | $44.37 | 353.96K |
| Q2 2018 | share | Increase | +66.17% | 161.82K shares | -1.76M | $39.19 | 406.36K |
| Q1 2018 | share | Decrease | -36.75% | -142.08K shares | -7.76M | $72.33 | 244.54K |
| Q4 2017 | share | Increase | +24.00% | 74.82K shares | 9.82M | $65.84 | 386.62K |
| Q3 2017 | share | Decrease | -14.19% | -51.54K shares | -1.18M | $50.12 | 311.80K |
| Q2 2017 | share | Decrease | -33.13% | -180K shares | -2.37M | $46.28 | 363.34K |
| Q1 2017 | share | Increase | +97.58% | 268.34K shares | 15.74M | $35.31 | 543.34K |
| Q4 2016 | share | Increase | +111.54% | 145K shares | 1.64M | $12.52 | 275K |
| Q3 2016 | share | Decrease | -7.14% | -10K shares | 417.5K | $13.85 | 130K |
| Q2 2016 | share | Decrease | -6.67% | -10K shares | -1.15M | $9.88 | 140K |
| Q1 2016 | share | Increase | +50.00% | 50K shares | 311K | $16.91 | 150K |